Development and evaluation of sustained-release Compritol ® 888 ATO matrix mini-tablets
first_published_at:Sept. 1, 2012, midnight / date_published:Sept. 1, 2012
Papers
-
01/09/2012 -
by
Matthew Roberts,
Daniele Vellucci,
Shabbir Mostafa,
Cedric Miolane,
Delphine Marchaud
Context: Sustained-release mini-tablets hold promise for pediatric drug delivery and as multiparticulate dosage forms.
Objective: Assess the feasibility of developing lipophilic matrix mini-tablets and examine the impact of Compritol® 888 …
